Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

TRAIL(+) human plasmacytoid dendritic cells kill tumor cells in vitro: mechanisms of imiquimod- and IFN-a-mediated antitumor reactivity.

TRAIL(+) human plasmacytoid dendritic cells kill tumor cells in vitro: mechanisms of imiquimod- and IFN-a-mediated antitumor reactivity. J Immunol. 2012 Feb 15; 188(4):1583-91.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.